Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Tumor cell-organized fibronectin is required to maintain a dormant breast cancer population

Lauren E. Barney, Christopher L. Hall, Alyssa D. Schwartz, Akia N. Parks, Christopher Sparages, Sualyneth Galarza, Manu O. Platt, Arthur M. Mercurio, Shelly R. Peyton
doi: https://doi.org/10.1101/686527
Lauren E. Barney
1Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher L. Hall
1Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyssa D. Schwartz
1Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akia N. Parks
2The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, GA 30332
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Sparages
1Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sualyneth Galarza
1Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manu O. Platt
2The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, GA 30332
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur M. Mercurio
3Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelly R. Peyton
1Department of Chemical Engineering, University of Massachusetts, Amherst, Amherst, MA 01003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: speyton@umass.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Tumors can undergo long periods of dormancy, with cancer cells entering a largely quiescent, non-proliferative state before reactivation and outgrowth. For a patient, these post-remission tumors are often drug resistant and highly aggressive, resulting in poor prognosis. To understand the role of the extracellular matrix (ECM) in regulating tumor dormancy, we created an in vitro cell culture system that combines carefully controlled ECM substrates with nutrient deprivation to observe entrance into and exit from dormancy with live imaging. We saw that cell populations capable of surviving entrance into long-term dormancy were heterogeneous, containing quiescent, cell cycle arrested, and actively proliferating cells. Cell populations that endured extended periods of serum-deprivation-induced dormancy formed an organized, fibrillar fibronectin matrix via αvβ3 and α5β1 integrin adhesion, ROCK-generated tension, and TGFβ2 stimulation. We surmised that the fibronectin matrix was primarily a mediator of cell survival, not proliferation, during the serum-deprivation stress, bacause cancer cell outgrowth after dormancy required MMP-2-mediated fibronectin degradation. Given the difficulty of animal models in observing entrance and exit from dormancy in real-time, we propose this approach as a new, in vitro method to study factors important in regulating dormancy, and we used it here to elucidate a role for fibronectin deposition and MMP activation.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 01, 2019.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tumor cell-organized fibronectin is required to maintain a dormant breast cancer population
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tumor cell-organized fibronectin is required to maintain a dormant breast cancer population
Lauren E. Barney, Christopher L. Hall, Alyssa D. Schwartz, Akia N. Parks, Christopher Sparages, Sualyneth Galarza, Manu O. Platt, Arthur M. Mercurio, Shelly R. Peyton
bioRxiv 686527; doi: https://doi.org/10.1101/686527
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Tumor cell-organized fibronectin is required to maintain a dormant breast cancer population
Lauren E. Barney, Christopher L. Hall, Alyssa D. Schwartz, Akia N. Parks, Christopher Sparages, Sualyneth Galarza, Manu O. Platt, Arthur M. Mercurio, Shelly R. Peyton
bioRxiv 686527; doi: https://doi.org/10.1101/686527

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4999)
  • Biochemistry (11203)
  • Bioengineering (8320)
  • Bioinformatics (28075)
  • Biophysics (14412)
  • Cancer Biology (11538)
  • Cell Biology (16610)
  • Clinical Trials (138)
  • Developmental Biology (9058)
  • Ecology (13691)
  • Epidemiology (2067)
  • Evolutionary Biology (17739)
  • Genetics (11892)
  • Genomics (16265)
  • Immunology (11367)
  • Microbiology (26897)
  • Molecular Biology (11024)
  • Neuroscience (58395)
  • Paleontology (432)
  • Pathology (1795)
  • Pharmacology and Toxicology (3090)
  • Physiology (4700)
  • Plant Biology (9973)
  • Scientific Communication and Education (1640)
  • Synthetic Biology (2768)
  • Systems Biology (7149)
  • Zoology (1565)